In the previous issue of the PolyMem® QuadraFoam® Quarterly, we discussed the continuous cleansing capabilities of PolyMem QuadraFoam dressings. Our focus in this issue is on PolyMem dressings’ ability to help relieve both persistent wound pain and procedure-related pain. In 1995, the American Pain Society termed pain the “fifth vital sign.” The wound care community has increasingly acknowledged the need to assess and manage patients’ pain in order to improve their quality of life. Wound pain includes the pain patients experience at dressing changes as well as persistent pain related to the wound itself. Patients with multiple comorbidities cannot always use NSAIDs or other pain medication to reduce the wound pain they are experiencing. Helping to decrease both wound-related pain and procedural pain can lead to a better relationship between caregivers and patients while improving patient outcomes. PolyMem QuadraFoam dressings continuously cleanse the wound bed (as discussed in Volume 1, Issue 3) and are non-adherent to the wound bed, usually eliminating any procedure-related pain caused by dressing changes. But more importantly, PolyMem QuadraFoam dressings help relieve both the intermittent and continuous wound pain patients often experience. The dressings have been shown to alter the response of an important group of pain sensing nerve endings that are throughout the body.+ These nerve endings are technically referred to as “nociceptors.” These pain-sensing nerve endings play important roles in the patient’s perception of wound pain and the creation of inflammation, bruising, and edema seen at and around an injury. The drug-free PolyMem dressings help relieve pain, inflammation, bruising, and edema at and around the wound. The robust localized inflammatory response required for healing the wound is not interrupted when using PolyMem dressings. Clinicians frequently report PolyMem dressings help reduce acute and chronic wound pain as well as procedural pain to such an extent that their patients’ need for either systemic or topical analgesia is often eliminated. Sincerely, Roger Sessions, D.O., FACEP Chairman and CEO
PolyMem, PolyMem Silver, Shapes by PolyMem and QuadraFoam are trademarks of Ferris, registered or pending in the US Patent and Trademark Office and in other countries. ©2008 Ferris Mfg. Corp. All rights reserved. 16W300 83rd Street, Burr Ridge, IL, USA 60527 MKL-364,REV-0,1208 |


















